Skip to main content
Premium Trial:

Request an Annual Quote

Roche's Bid to Acquire Illumina Topped Readers' Interest in 2012

NEW YORK (GenomeWeb News) – Roche's bid to acquire Illumina, which was ultimately unsuccessful in the early part of 2012, topped our list of most-viewed articles on GenomeWeb Daily News for the year.

A series of articles on Roche's pursuit and Illumina's efforts to fend off the hostile takeover bid claimed six of the top 10 most-viewed articles on GWDN for 2012:

1) Illumina Creates Poison Pill in Response to Roche Bid
2) Roche Announces $5.7 Billion Hostile Takeover Bid for Illumina
3) Shareholders File Lawsuit Against Illumina
4) Roche Names Proposed Board Nominees for Illumina
5) Shares of Sequencing Instrument Makers Fall as Oxford Nanopore Unveils Platforms
6) Roche Claims 'Other Options' If Illumina Deal Fails
7) Roche Extends Tender Offer for Illumina
8) Illumina Confirms Unsolicited Bid for Complete Genomics
9) Promega Awarded $52M in Suit Against Life Technologies
10) Complete Genomics, BGI Agree to $117.6M Merger

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.